UCLA researchers in the Department of Chemistry and Biochemistry have developed improved bright and non-toxic polymethine dyes that will expand current medical optical imaging capabilities.
As compared to light in the visible and near infrared (NIR) regions of the electromagnetic spectrum, light in the shortwave infrared (SWIR) region exhibits less interaction with animal tissue leading to deeper images with enhanced resolution images. Materials that emit light in the SWIR region are thus superior contrast agents than their visible and NIR counterparts and are ideal for use in tissue imaging.Quantum dots, carbon nanotubes, and rare-earth metal-based probes are commonly employed for SWIR imaging, yet concern over these materials’ toxicity continues to limit their utility.Similarly, small organic molecules with SWIR emission known as donor-acceptor-donor small molecules have been presented for imaging, but these molecules necessitate excitation in the NIR and thus cannot take full advantage of the enhanced resolution and depth penetration of the SWIR region.
UCLA researchers in the Department of Chemistry and Biochemistry have developed improved bright and non-toxic polymethine dyes that will expand current medical optical imaging capabilities. The improved polymethine fluorophores exhibit a wider range of photophysical properties than existing imaging materials and will allow for the extraction of more useful and detailed information regarding complex biological systems in vivo.
|United States Of America||Published Application||20200140404||05/07/2020||2017-726|
|European Patent Office||Published Application||3634397||04/15/2020||2017-726|
Additional Patents Pending
polymethine dyes; polymethine fluorophores; SWIR imaging; image-guided surgery; fluorescence imaging